Detalhe da pesquisa
1.
Gemcitabine-Ibandronate Conjugate Enables the Bone-Targeted Combination Therapy in Bone Cancer: Synthesis and Efficacy in Combination with Docetaxel.
Bioconjug Chem
; 32(12): 2530-2539, 2021 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34779607
2.
First-in-Human Phase I Study of MBC-11, a Novel Bone-Targeted Cytarabine-Etidronate Conjugate in Patients with Cancer-Induced Bone Disease.
Oncologist
; 24(3): 303-e102, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30413669
3.
Bisphosphonate conjugation for bone specific drug targeting.
Bone Rep
; 9: 47-60, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29992180
4.
A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites.
Bone
; 47(1): 12-22, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20233612
5.
Bisphosphonate derivatives of nucleoside antimetabolites: hydrolytic stability and hydroxyapatite adsorption of 5'-beta,gamma-methylene and 5'-beta,gamma-(1-hydroxyethylidene) triphosphates of 5-fluorouridine and ara-cytidine.
J Org Chem
; 73(11): 4123-30, 2008 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-18473440
6.
Scaleable and efficient synthesis of 2'-deoxy-2'-N-phthaloyl nucleoside phosphoramidites for oligonucleotide synthesis.
Bioorg Med Chem Lett
; 12(22): 3345-7, 2002 Nov 18.
Artigo
Inglês
| MEDLINE | ID: mdl-12392748